Burden of Community Acquired Pneumonia

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the research gaps as outlined in the specific RFP.

Studies that will be considered for Pfizer support will focus on evaluating the burden of community acquired pneumonia, including but not limited to pneumococcal pneumonia, as well as risk factors for and complications from disease.

Projects submitted may include: • Quantification of the disease burden of community acquired pneumonia in adult population • Exacerbations of chronic disease (e.g., CHF, diabetes, others) either leading to hospitalization or following hospitalization due to community acquired pneumonia • Long term declines in quality of life following pneumococcal disease syndromes (pneumonia, IPD) • Quantification of impact of risk factor for community acquired pneumonia/ pneumococcal disease • Identification of new risk factors for community acquired pneumonia / pneumococcal disease

Grant Application due date: June 9, 2021

Agency Website

Eligibility Requirements

Geographic Scope: U.S.

• The institution and principal investigator (PI) must be based in one of the eligible countries noted above. • Only organizations are eligible to receive grants, not individuals or medical practice groups. • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. • Applicant must be affiliated with a host institution



Amount Description

Individual studies requesting up to $150,000 will be considered. The estimated total available budget related to this RFP is $300,000.

Funding Type





Medical - Basic Science
Medical - Clinical Science

External Deadline

June 9, 2021